These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 241276)

  • 21. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G; Cristodorescu R; Deutsch G; Berger E
    Agressologie; 1977; 18(3):167-71. PubMed ID: 920909
    [No Abstract]   [Full Text] [Related]  

  • 23. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D; Achilli L
    Minerva Cardioangiol; 1984 Sep; 32(9):581-7. PubMed ID: 6514202
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diuretic treatment with ethacrynic acid after open heart surgery].
    Oelert H; Demberg K; Sebening F
    Thoraxchir Vask Chir; 1972 Feb; 20(1):81-9. PubMed ID: 4537174
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of acute tissue injury on zinc metabolism in man.
    Lindeman RD; Bottomley RG; Cornelison RL; Jacobs LA
    J Lab Clin Med; 1972 Mar; 79(3):452-60. PubMed ID: 5061398
    [No Abstract]   [Full Text] [Related]  

  • 28. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
    Nardoni A; di Piazza V; Moretti V; Copetti R; Trinco G; Geatti O
    Clin Ter; 1988 May; 125(4):287-90. PubMed ID: 2974364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
    Kabakov AI; Zharov EI
    Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventive measures against postoperative secondary aldosteronism following open heart surgery--planned administration of injective aldosterone antagonist].
    Shirakura R; Hirose H; Nakano S; Matsuda H; Ohtani M; Taniguti H; Nomura H; Kawashima Y
    Rinsho Kyobu Geka; 1987; 7(1):45-9. PubMed ID: 9301756
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aldosterone antagonists in coronary insufficiency].
    Osswald H
    Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of modified preoperative, and postoperative potassium supplementation on the incidence of postoperative ventricular arrhythmias.
    Shanahan EA; Anderson ST; Morris KN
    J Thorac Cardiovasc Surg; 1969 Mar; 57(3):413-21. PubMed ID: 5773210
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of the inotropic effect of potassium canrenoate by determining systolic time intervals].
    Vitolo E; Gambini E; Larovere MT; Rusconi F; Vitali GM
    Boll Soc Ital Cardiol; 1979; 24(7):775-7. PubMed ID: 554665
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of prophylactic use of furosemide on renal function during open heart surgery.
    Nuutinen L; Hollmén A
    Ann Chir Gynaecol; 1976; 65(4):258-66. PubMed ID: 970902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of potassium canrenoate on serum magnesium levels after extracorporeal circulation].
    Tsuji K; Nawa S; Kino K; Teramoto S; Hayashi K
    Kokyu To Junkan; 1992 Aug; 40(8):813-8. PubMed ID: 1529178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
    Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
    [No Abstract]   [Full Text] [Related]  

  • 37. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
    Ruggerini R; Mazzocchi F; Albini G; Cifalinò M
    Minerva Anestesiol; 1979 Sep; 45(9):687-90. PubMed ID: 117400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Denis B; Dimitriou R; Machecourt J; Wolf JE; Page E; Reboud JP
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():35-40. PubMed ID: 6428361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
    J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F; Ambrosioni E
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.